Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2026 is 84.19% vs 0.00% in Sep 2025
Consolidate Net Profit
YoY Growth in quarter ended Sep 2026 is 96.92% vs 0.00% in Sep 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2026 is 89.57% vs 0.00% in Sep 2025
Interest
YoY Growth in quarter ended Sep 2026 is 13.58% vs 0.00% in Sep 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025
Compare Quarterly Results Of Fredun Pharma With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2026 is 17.25% vs 7.13% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 84.19% vs 0.00% in Sep 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2026 is 41.43% vs 21.80% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 96.92% vs 0.00% in Sep 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2026 is 29.35% vs 13.37% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 89.57% vs 0.00% in Sep 2025
Quarterly - Interest
QoQ Growth in quarter ended Sep 2026 is 1.86% vs -40.51% in Jun 2026
YoY Growth in quarter ended Sep 2026 is 13.58% vs 0.00% in Sep 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2026 has improved from Jun 2026
YoY Growth in quarter ended Sep 2026 has improved from Sep 2025